Skip to content
2000
Volume 26, Issue 6
  • ISSN: 1389-2010
  • E-ISSN: 1873-4316

Abstract

Objective

This study aimed to investigate the protective effect and mechanism of Astragalus polysaccharide (APS) on autoimmune encephalomyelitis.

Methods

C57BL/6 mice were randomly divided into the blank control group, EAE group, and APS intervention group (n=15/group). The Experimental Autoimmune Encephalomyelitis (EAE) mouse model was established by active immunization. The pathological changes in the spinal cord were evaluated by Hematoxylin-eosin (HE) and Luxol Fast Blue (LFB) staining. The number of CD11b+ Gr-1+ myeloid-derived suppressor cells (MDSCs) in the spleen tissues of mice in each group was determined by immunofluorescence staining. The expression of Arginase-1 in the spinal cord and spleen of each group was detected by immunofluorescence double staining. The TNF-α, IL-6, and Arginase-1 levels in the spleen were detected by ELISA assay. A western blot was used to detect the protein expression of the AMPK/JAK/STAT3/Arginase-1 signaling pathway.

Results

After the intervention of APS, the incidence of autoimmune encephalomyelitis in mice of the APS group was significantly lower than that in the EAE group, and the intervention of APS could significantly delay the onset time in the EAE mice, and the score of neurological function deficit in mice was significantly lower than that in EAE group ( < 0.05). APS intervention could reduce myelin loss and improve the inflammatory response of EAE mice. Moreover, it could induce the expression of CD11b+ GR-1 + bone MDSCs in the spleen and increase the expression of Arginase-1 in the spinal cord and spleen. This study further demonstrated that APS can protect EAE mice by activating the AMPK/JAK/STAT3/Arginase-1 signaling pathway.

Conclusion

After the intervention of APS, myelin loss and inflammatory response of EAE mice were effectively controlled. APS promoted the secretion of Arginase-1 by activating MDSCs and inhibited CD4+T cells by activating AMPK/JAK/STAT3/Arginase-1 signaling pathway, thus improving the clinical symptoms and disease progression of EAE mice.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cpb/10.2174/0113892010314302240902073112
2024-09-16
2025-09-16

  • From This Site

    /content/journals/cpb/10.2174/0113892010314302240902073112
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. StephensonJ. NutmaE. van der ValkP. AmorS. Inflammation in CNS neurodegenerative diseases.Immunology2018154220421910.1111/imm.1292229513402
     [Google Scholar]
  2. McGinleyM.P. GoldschmidtC.H. Rae-GrantA.D. Diagnosis and treatment of multiple sclerosis.JAMA2021325876577910.1001/jama.2020.2685833620411
     [Google Scholar]
  3. ProcacciniC. De RosaV. PucinoV. FormisanoL. MatareseG. Animal models of multiple sclerosis.Eur. J. Pharmacol.201575918219110.1016/j.ejphar.2015.03.04225823807
     [Google Scholar]
  4. WanX. PeiW. ZhangY. ZhangL. ShahzadK.A. XuT. ShenC. Inconsistence between number and function of autoreactive T cells in the course of experimental autoimmune encephalomyelitis.Immunol. Invest.201847111710.1080/08820139.2017.136700828872930
     [Google Scholar]
  5. CrossA. RileyC. Treatment of multiple sclerosis.Continuum20222841025105110.1212/CON.000000000000117035938656
     [Google Scholar]
  6. GabrilovichD.I. Ostrand-RosenbergS. BronteV. Coordinated regulation of myeloid cells by tumours.Nat. Rev. Immunol.201212425326810.1038/nri317522437938
     [Google Scholar]
  7. BitschR. KurzayA. Özbay KurtF. De La TorreC. LasserS. LepperA. SiebenmorgenA. MüllerV. AltevogtP. UtikalJ. UmanskyV. STAT3 inhibitor Napabucasin abrogates MDSC immunosuppressive capacity and prolongs survival of melanoma-bearing mice.J. Immunother. Cancer2022103e00438410.1136/jitc‑2021‑00438435301236
     [Google Scholar]
  8. NiuF. YuY. LiZ. RenY. LiZ. YeQ. LiuP. JiC. QianL. XiongY. Arginase: An emerging and promising therapeutic target for cancer treatment.Biomed. Pharmacother.202214911284010.1016/j.biopha.2022.11284035316752
     [Google Scholar]
  9. KusmartsevS. NefedovaY. YoderD. GabrilovichD.I. Antigen-specific inhibition of CD8+ T cell response by immature myeloid cells in cancer is mediated by reactive oxygen species.J. Immunol.2004172298999910.4049/jimmunol.172.2.98914707072
     [Google Scholar]
  10. SunY. JingY. HuangM. MaJ. PengX. WangJ. LiG. ChengX. The PD-1/PD-Ls pathway is up-regulated during the suppression of experimental autoimmune encephalomyelitis treated by Astragalus polysaccharides.J. Neuroimmunol.2019332789010.1016/j.jneuroim.2019.03.01930981049
     [Google Scholar]
  11. GuoM.F. DaiY.J. GaoJ.R. ChenP.J. Uncovering the mechanism of astragalus membranaceus in the treatment of diabetic nephropathy based on network pharmacology.J. Diabetes Res.2020202011310.1155/2020/594730432215271
     [Google Scholar]
  12. LiuX. MaJ. DingG. GongQ. WangY. YuH. ChengX. Microglia polarization from M1 toward M2 phenotype is promoted by Astragalus Polysaccharides mediated through inhibition of miR‐155 in experimental autoimmune encephalomyelitis.Oxid. Med. Cell. Longev.202120211575345210.1155/2021/575345234976303
     [Google Scholar]
  13. ZhaoY. MaJ. DingG. WangY. YuH. ChengX. Astragalus polysaccharides promote neural stem cells-derived oligodendrogenesis through attenuating CD8+T cell infiltration in experimental autoimmune encephalomyelitis.Int. Immunopharmacol.202412611130310.1016/j.intimp.2023.11130338043269
     [Google Scholar]
  14. PeruginiJ. Di MercurioE. TossettaG. SeveriI. MonacoF. ReguzzoniM. TomasettiM. DaniC. CintiS. GiordanoA. Biological effects of ciliary neurotrophic factor on hMADS adipocytes.Front. Endocrinol.20191076810.3389/fendo.2019.0076831781039
     [Google Scholar]
  15. ZhaoQ. ChengY. XiongY. LTF regulates the immune microenvironment of prostate cancer through JAK/STAT3 pathway.Front. Oncol.20211169211710.3389/fonc.2021.69211734868909
     [Google Scholar]
  16. PerdaensO. van PeschV. Molecular mechanisms of immunosenescene and inflammaging: Relevance to the immunopathogenesis and treatment of multiple sclerosis.Front. Neurol.20221281151810.3389/fneur.2021.81151835281989
     [Google Scholar]
  17. PapeK. TamouzaR. LeboyerM. ZippF. Immunoneuropsychiatry — Novel perspectives on brain disorders.Nat. Rev. Neurol.201915631732810.1038/s41582‑019‑0174‑430988501
     [Google Scholar]
  18. DongN. LiX. XueC. WangC. XuX. BiC. ShanA. LiD. Astragalus polysaccharides attenuated inflammation and balanced the gut microflora in mice challenged with Salmonella typhimurium.Int. Immunopharmacol.20197410568110.1016/j.intimp.2019.10568131220694
     [Google Scholar]
  19. WangG. LinW. ZhaoR. LinN. Effects of six polysaccharides extracted from plants on the immunological cells of mice.Wei Sheng Yen Chiu200837557758019069658
     [Google Scholar]
  20. PengY. DengX. YangS. NieW. TangY. Progress in mechanism of astragalus membranaceus and its chemical constituents on multiple sclerosis.Chin. J. Integr. Med.2023291899510.1007/s11655‑022‑3535‑635809178
     [Google Scholar]
  21. YeN. CruzJ. PengX. MaJ. ZhangA. ChengX. Remyelination is enhanced by Astragalus polysaccharides through inducing the differentiation of oligodendrocytes from neural stem cells in cuprizone model of demyelination.Brain Res.2021176314745910.1016/j.brainres.2021.14745933794147
     [Google Scholar]
  22. HackS.P. ZhuA.X. WangY. Augmenting anticancer immunity through combined targeting of angiogenic and PD-1/PD-L1 pathways: Challenges and opportunities.Front. Immunol.20201159887710.3389/fimmu.2020.59887733250900
     [Google Scholar]
  23. GrothC. HuX. WeberR. FlemingV. AltevogtP. UtikalJ. UmanskyV. Immunosuppression mediated by myeloid-derived suppressor cells (MDSCs) during tumour progression.Br. J. Cancer20191201162510.1038/s41416‑018‑0333‑130413826
     [Google Scholar]
  24. LiT. Bou-DarghamM.J. FultangN. LiX. PearW.S. SunH. ChenY.H. c-Rel-dependent monocytes are potent immune suppressor cells in cancer.J. Leukoc. Biol.2022112484585910.1002/JLB.1MA0422‑518RR35694784
     [Google Scholar]
  25. ReddP.S. IbrahimM.L. KlementJ.D. SharmanS.K. PaschallA.V. YangD. Nayak-KapoorA. LiuK. SETD1B activates iNOS expression in myeloid-derived suppressor cells.Cancer Res.201777112834284310.1158/0008‑5472.CAN‑16‑223828381543
     [Google Scholar]
  26. NomanM.Z. DesantisG. JanjiB. HasmimM. KarrayS. DessenP. BronteV. ChouaibS. PD-L1 is a novel direct target of HIF-1α, and its blockade under hypoxia enhanced MDSC-mediated T cell activation.J. Exp. Med.2014211578179010.1084/jem.2013191624778419
     [Google Scholar]
  27. PilancP. WojnickiK. RouraA.J. CyranowskiS. Ellert-MiklaszewskaA. OchockaN. GielniewskiB. GrzybowskiM.M. BłaszczykR. StańczakP.S. DobrzańskiP. KaminskaB. A novel oral arginase 1/2 inhibitor enhances the antitumor effect of PD-1 inhibition in murine experimental gliomas by altering the immunosuppressive environment.Front. Oncol.20211170346510.3389/fonc.2021.70346534504786
     [Google Scholar]
  28. SafarzadehE. MohammadiA. MansooriB. DuijfP.H.G. HashemzadehS. KhazeV. KazemiT. DerakhshaniA. SilvestrisN. BaradaranB. STAT3 silencing and TLR7/8 pathway activation repolarize and suppress myeloid-derived suppressor cells from breast cancer patients.Front. Immunol.20211161321510.3389/fimmu.2020.61321533679700
     [Google Scholar]
/content/journals/cpb/10.2174/0113892010314302240902073112
Loading
The Protective Effect of Astragalus Polysaccharide on Experimental Autoimmune Encephalomyelitis in Mice by Activating the AMPK/JAK/ STAT3/Arginase-1 Signaling Pathway
Current Pharmaceutical Biotechnology 26, 863 (2025); https://doi.org/10.2174/0113892010314302240902073112
/content/journals/cpb/10.2174/0113892010314302240902073112
/content/journals/cpb/10.2174/0113892010314302240902073112
Loading

Data & Media loading...

Supplements

Supplementary material is available on the publisher's website along with the published article.

file format download Download

  • Article Type:     Research Article
Keyword(s): AMPK; Arginase-1; Astragalus polysaccharide; experimental autoimmune encephalomyelitis; marrow-derived suppressor cells; Multiple sclerosis

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test